Home Disintegration, In vitro Dissolution, and Drug Release Kinetics Profiles of k-Carrageenan-based Nutraceutical Hard-shell Capsules Containing Salicylamide
Article Open Access

Disintegration, In vitro Dissolution, and Drug Release Kinetics Profiles of k-Carrageenan-based Nutraceutical Hard-shell Capsules Containing Salicylamide

  • Pratiwi Pudjiastuti EMAIL logo , Siti Wafiroh , Esti Hendradi , Handoko Darmokoesoemo , Muji Harsini , M. Al Rizqi Dharma Fauzi , Lutfun Nahar and Satyajit D. Sarker
Published/Copyright: April 7, 2020

Abstract

The release of drugs from solid drug delivery materials has been studied intently in recent years. Quantitative analyses achieved from in vitro dissolution becomes easier if a zero-order mathematical model is used. Non-gelatin nutraceutical hard-shell capsules of zero size (approximately 0.7-0.8 cm) were produced from carrageenan-based natural polymers, namely carrageenan-alginate (CA) and carrageenan-starch (CS). Disintegration, dissolution and zero-order drug release kinetics of hard-shell capsules containing 100 mg of salicylamide were studied. The disintegration time of CA and CS were observed to be less than 30 min for both CA and CS. In vitro dissolution profile showed that the percentage dissolution of CA capsules was better at pH 4.5, while that of CS was poor at pH 1.2, 4.5 and 6.8. Determination of drug release kinetics profiles of carrageenan-based hardshell capsules utilized the Noyes-Whitney and Peppas-Sahlin modification rules for zero-order. The drug release from carrageenan-based capsules followed zero-order kinetics, especially at pH 6.8, and was compared to the Higuchi model. Salicylamide in CA hard-shell capsules at a pH 6.8 had a release rate constant (kH) of 2.91 %(ppm/ ppm) min-1/2, while the release rate constant of CS was 0.36 %(ppm/ppm) min-1.

1 Introduction

Commercially available hard-shell capsules are generally made from gelatin, which is produced from bone and skin of cows, pigs or buffalos. Gelatin hard-shell capsules were introduced in 1931 by Arthur Cotton [1]. The first non-gelatin hard-shell capsule was produced in 1989 with the trademark of Vegicaps, and it was made from a material, hydroxypropyl methylcellulose (HPMC), that is appropriate for vegetarians or vegans. As an addition, carrageenan-based non-gelatin hard-shell capsules have been patented and produced, i.e. Quali-V [2].

Carrageenan is one of the most important commercial marine products, along with alginates and agars. Indonesia and the Philippines are two countries that produce much of the carrageenan for the rest world [3]. It is extracted from red seaweeds, especially from the Rodhophyceae family, including Chondruscripus, C. ocellatus, Eucheuma cottonii, E. spinosum, E. gelatinae, Furcellaria fatigiata, Gigartina stellata, G. acicularis, G. pistillata, G. canaliculata, G. chamissol, G. radula, G. skottsbergii, Gymnogongrus furcellatus, Hypneamusciformis and H. spicifera [4].

Carrageenan is a sulfated polysaccharide that is classified based on the position of the link of anhydrogalactose bond and the number and position of ester sulfate. Subclasses of carrageenans include α, β, k, i, and q [5] as well as m and ν [6]. k-Carrageenan is mainly obtained from tropical seaweed of the Eucheumacottonii or Kappaphycus alvarezii species. Commercial k-carrageenan contains an ester sulfate and D-galactose-4-sulfate 3,6-anhydro-D-galactose at levels of approximately 25 to 30% and 28-35%, respectively [5,6]. The molecular weight of carrageenan is in the range of 100 to 1000 kDa. It is a strong anionic polymer possessing excellent gelling, thickening, stabilizing [5,7] and emulsifying [6] properties.

Carrageenan is also used for non-foods industries, including as a pharmaceutical excipient and as a medicine [6]. Carrageenan has some bioactivities, such as antioxidant, antimicrobial towards Salmonella typhimurium and E. coli O157:H7 strains, immunomodulatory, antiviral, antitumor, anticoagulant and antithrombotic properties [8]. It is regarded as a nontoxic and nonirritating agent for use in nonparenteral formulations, and it is well known as an anti-inflammatory agent [9]. Alginate is used as a dietary fiber, and it can stimulate the immune system, reduce intestinal absorption, increase satiety, reduce glycemic index and modulate colonic microflora [8]. Alginate can be consumed as a beverage to reduce the blood sugar level [10].

Due to these important consumer-targeted properties, combinations of carrageenan-alginate and carrageenan-starch are being developed as new products as non-gelatin nutraceutical (nutrition and pharmaceutical) hardshell capsules. This nutraceutical capsule offers unique inherent acid-resistant natural polymer properties. Thus, the capsule resists disintegration in the stomach but opens immediately once the pH rises above 4.5, out of the acidic environment of the stomach. Disintegration starts approximately 25 minutes after the ingestion of the capsule, and the dissolution of drugs begin after 50 minutes. The complete release of the gelatin hard-shell capsule takes place in the small intestine around 20 min after the onset of release when the pH shifts more to a neutral pH of 6.8. Therefore, the nutraceutical capsule is acid-resistant and delivers to the small intestine [11].

In vitro dissolution is an important factor in drug absorption, distribution, metabolism and excretion (ADME). Dissolution is defined as the rate of transfer of mass from the dosage form into a liquid medium at a suitable temperature for standardization [12]. Many kinetics models have been used to describe drug dissolution and release from solid dosage forms [13]. Drug release can be divided into several modes, including immediate release, modified-release, extended-release, controlled-release and pulsatile-release [12]. Salicylamide is a non-steroidal and anti-inflammatory agent; it has analgesic, antipyretic and platelet inhibitory actions. Salicylamide is stable in acid and weak base, so it can be used as a model of drug release kinetics. Carrageenan can be used to control the release of drugs, improve the dissolution of drugs and has been tested for its potential use in broader biomedical application [6,14].

Information about drug release kinetics of carrageenan-based hard-shell capsules is still limited. There are reports on drug release properties during diffusion from layer-by-layer self-assembled κ- carrageenan-chitosan nanocapsules [15], application of κ-carrageenan as a sustained-release matrix in floating tablets containing sodium salicylate [16] and drug release kinetics and front movement in matrix tablets containing diltiazem or metoprolol/λ-carrageenan complexes [17]. However, none of these reports investigated drug release kinetics from nutraceutical hard-shell capsules. This paper reports the study of disintegration, dissolution and drug release kinetic profiles of k-carrageenan-based nutraceutical hard-shell capsules containing salicylamide.

2 Experimental Method

2.1 Materials

Food grade k-carrageenan and sodium alginate were purchased from Kappa Carrageenan Nusantara, Inc., Pasuruan, Indonesia. Carrageenan-alginate (CA) and carrageenan-starch (CS) hard-shell capsules were prepared in Kapsulindo Nusantara, Inc., Bogor, Indonesia. All water used was deionized.

2.2 Preparation of Hard-Shell Capsules

Carrageenan and alginate were combined and mixed into the water gently at room temperature. Then, the temperature was raised to 70oC to create a homogeneous solution. The solution was poured into a bath and printed using zero size dipping bars and dried at room temperature for 4 h to produce capsules. The same procedure was conducted to create CS capsules.

2.3 Disintegration Test

The disintegration of capsules was tested using a disintegration tester type Veego-202397. Six chambers were filled with 900 mL of water. Six carrageenan-based (CA and CS) capsules were put in each basket and heated at 37±0.5oC. The apparatuses were slowly rotated until hard-shell capsules were disintegrated completely.

2.4 Dissolution Test and Release Kinetics Analyses

An Erweka Dissolution Tester type DT 820 was adjusted to 37oC and rotated at 100 rpm. Three of each of the carrageenan-based (including CA and CS) zero size capsules were filled with 100 mg of salicylamide and put in the basket holder, which contained 900 mL of medium. The dissolution media was created as described by the United States Pharmacopeia (USP) at pH 1.2 (0.1 mol/L HCl), pH 4.5 (citrate buffer) and pH 6.8 (phosphate buffer). All media were calibrated with a pH meter prior to each assay. Samples (5 mL) were taken after 5, 10, 15, 20, 30, 45 and 60 min, and volumes were maintained by refilling with 5 mL of media. All samples were analyzed using a UV-Vis spectrometer at 298 and 299 nm for pH 4.5 and 1.2 / 6.8, respectively. The data were analyzed statistically to obtain dissolution and kinetics profiles in all media. Drug release kinetics profiles utilized the Noyes-Whitney rules for zero-order calculation. The best profile of the graphs from the Noyes-Whitney and Peppas-Sahlin equations were used to determine kH using the Higuchi model.

Ethical approval: The conducted research is not related to either human or animal use.

3 Results and Discussion

3.1 Disintegration of CA and CS

The CA and CS hard-shell capsules disintegrated completely by 12.80 and 25.79 min, respectively as shown in Table 1. All of the capsules ruptured within 30 min, which meets the USP recommendation for the disintegration of dietary supplements [19].

Table 1

Disintegration times of capsules.

CapsulesCA (min)CS (min)
111.2820.04
211.2825.52
312.1327.02
413.4727.02
514.3327.58
614.3327.58
Mean12.8025.79
Standard Deviation1.432.92

Starch is a semicrystalline material that contains the crystalline form of a linear structure of amylose and the amorphous form of branched amylopectin [20], while sodium alginate is a linear unbranched copolymer composed of β-D-mannuronic acid (M) and α-L-guluronic acid (G) linked by 1→4 glycosidic bonds and appears as an amorf [21]. Therefore, the structure of CS is more rigid than CA. This rigid structure likely prevents CS from being ruptured by the medium better than CA; this model correlates with the higher disintegration time of CS relative to CA. As an addition, Glube et al. reported that hard-shell capsules made of hypromellose (HPMC)–carrageenan that contained green tea extracts disintegrated within 20 min [19]. It is seen that the order of disintegration time from the slowest to the fastest time would be CS > HPMC-carrageenan > CA > gelatin. Therefore, relative to gelatin, the disintegration time of CA was better than other materials, which was HPMC in this case.

3.2 Dissolution and release kinetics analyses of salicylamide released from CA and CS

The dissolution of salicylamide from hard-shell capsules of CA reached approximately 70% at pH 4.5 within one hour (Figure 1a), while in CS (Figure 1b), it was poorly dissolved in all of the media conditions compared to CA hard-shell capsules. The disintegration test does not require the drug to be inside the capsules (USP NF-32), while the dissolution test requires it (USP 711). The salicylamide substance enters into the solvent to produce a solution. Interactions (especially hydrogen bonds) between salicylamide and CA and CS might slow the solvation process. The percentage of dissolution of salicylamide from the hard-shell capsules of CA and CS at pH 1.2, 4.5 and 6.8 is shown in Figure 1. In general, salicylamide dissolution increased over time in all three media.

Figure 1 Dissolution profile of salicylamide released from (a) CA and (b) CS capsules at pH 1.2, 4.5 and 6.8. The dissolution of the drug capsules was carried out in triplicate for each formulation, and results are reported as averages +/- standard deviation.
Figure 1

Dissolution profile of salicylamide released from (a) CA and (b) CS capsules at pH 1.2, 4.5 and 6.8. The dissolution of the drug capsules was carried out in triplicate for each formulation, and results are reported as averages +/- standard deviation.

The differences of dissolution may be due to a variety of characteristics of the matrix material, such as composition, structure, gelling, pH, temperature and ionic strength [22]. Chiwele et al. reported that the empty hard-shell capsules of gelatin, gelatin-PEG (polyethylene glycol) and HPMC at pH under 5.8 and at 10oC to 55oC dissolved rapidly, while gelatin and gelatin-PEG did not dissolve at a temperature below 30oC [23]. There was a significant increase in dissolution for capsules at pH 4.5 shown in Figure 1b. One possible explanation could be that the capsules were significantly dissolved at 50 min, which increased the dissolution of salicylamide into the medium exponentially.

Many mathematical models for determining drug release from solid dosage forms are available: the Noyes-Whitney rule, Higuchi, Hixson-Crowell, Korsmeyer-Peppas, Baker-Romdale, Weibull, Hopenberg and Gompertz model are used routinely. In this experiment, the mathematical model of drug release used is shown in equation (1), a modification of the Noyes-Whitney equation, for zero-order release kinetics calculations [13,18].

(1)Qt=Q0+K0t

In equation (1), Qt is the amount of drug dissolved in solution at time t, Q0 is the initial amount of drug in the solution (typically, Q0 = 0), and k0 is the zero-order release constant. Costa et al. reported that the dosage forms of drugs following zero-order release are the ideal model of drug release [13]. The logarithmic form of equation (1) is shown in equation (2):

(2)logQt=logK0+logt

The kinetics of the release of the drug can be classified as zero or first-order. The drug release in this experiment used the Noyes-Whitney equation model. Figure 2 compares a zero-order kinetic model to the drug release profile of salicylamide from CA hard-shell capsules. Since the only pH where salicylamide dissolved up to 80% was 4.5 (Figure 2b), there was only one kinetic profile that could be calculated. The salicylamide was released in the CA capsules more quickly at pH 4.5, and Figure 2b also shows linearity. The zero-order release constants of salicylamide in CA at pH 1.2 (Figure 2a) and 4.5 were 3.28 and 4.14 ppm/min (Table 2). The zero-order release constant of salicylamide in CA at pH 4.5 (Figure 2b) was 4.14 ppm/min (Table 2). Therefore, we suggest further study of CA capsules at pH 4.5. Even though CA capsules had poor solubility at pH 1.2 and 6.8 (Figure 2c), we also suggest further study for medicines with long release time that would be suitable for these features.

Figure 2 The zero-order drug release profile of salicylamide from CA capsules at pH (a) 1.2, (b) 4.5, and (c) 6.8.
Figure 2

The zero-order drug release profile of salicylamide from CA capsules at pH (a) 1.2, (b) 4.5, and (c) 6.8.

Table 2

The ko and R2 value of zero-order kinetics of carrageenan-based hard-shell capsules

pHk0 CA

ppm/min
R2k0 CS

ppm/min
R2
1.23.280.900.0580.87
4.54.140.980.230.92
6.80.460.840.0670.82

What seems interesting is that the capsules exhibit good solubility in a weakly acidic environment but not in either strongly acidic or more basic environments. No research to support or explain these results could be found. However, one possible explanation could be that the solubility of carrageenan might be affected by its sulfate groups. A citrate buffer solution that created a weakly acidic environment might increase its solubility by decreasing intramolecular hydrogen bonding in carrageenan’s secondary structure, as this structure is the main feature of carrageenan’s gelling ability [23]. Thus, when intramolecular interactions are broken, carrageenan would be expected to dissolve easily. This might not happen at pH 1.2 and pH 6.8, where HCl and phosphate buffers were used, because the buffer molecule itself could not form hydrogen bonds. Finally, since CS capsules have poor solubility at all pH values examined, release kinetic profiles could not be developed for the material due to Peppas-Sahlin’s rules [25]. Thus, we suggest that further research related to the dissolution time of CS capsules for more than 1 h should be conducted. The zero-order kinetic constants for CA capsules were 3.27 and 4.14 ppm/min (Table 2) for pH 1.2 and 4.5, respectively.

Analysis of drug release from carrageenan-based hard-shell capsules resulted in linear graphs that followed zero-order kinetics in the Noyes-Whitney model and were good mathematically and kinetically modeled at pH 6.8. This pH was applied to investigate the diffusion coefficient using the Higuchi model. Figure 3 represents the drug release of salicylamide in CA and CS hard capsules at pH 6.8 using the Higuchi model [12]. The graphs resulted from the Higuchi model calculation (Figure 3) represented the release kinetics process of drugs that were released from a swellable polymer, where the graph was plotted from the amount of drug released against the square-root of time. The simplified mathematical form of the Higuchi model is shown by equation (3).

Figure 3 The Higuchi model of drug release of salicylamide in hard-shell (a) CA and (b) CS capsules at pH 6.8
Figure 3

The Higuchi model of drug release of salicylamide in hard-shell (a) CA and (b) CS capsules at pH 6.8

(3)Qt=kHt

In this equation, Qt is the amount of drug released at time t, and kH is the release rate constant for the Higuchi model. This model features the release from both planar and spherical surfaces, where two geometric systems have been considered: the undirectional leaching of a simple planar surface and three-dimensional leaching from a spherical pellet [26].

We chose to examine the data at pH 6.8 because of its good linearity in Figure 3b compared to the other results, even though the capsules were less soluble in this environment. Another reason to be highlighted was that the only parameter affected by the acidity was the rate of release, but all capsules dissolved eventually. Therefore, capsules could still be used at every pH for any drug that meets compatible properties.

The graph shows that salicylamide in CA is released with a rate constant (kH) of 2.91 %(ppm/ppm) min-1/2(Figure 3a), while CS was 0.36 %(ppm/ppm) min-1/2(Figure 3b) at pH 6.8. At pH 6.8, the hard-shell capsule of CA has a bigger kH than does CS. They had diffusion coefficients that were large, and CA releases more under that condition. Finally, developments are needed for this study to be applied in the human body. In vivo studies must be performed to support this information with respect to toxic dosages. One example might be work similar to that carried out by Zhang et al. in which they studied nanoparticular melamine in a mouse model [27].

4 Conclusions

CA had lower stability or was more readily dissolved in a weaker acid medium (pH 4.5) than other natural, carbohydrate-based polymers. Salicylamide in CA was released into the acidic medium more readily than CS.

One reason to explain the phenomenon is that starch has smaller membrane pores and is more stable in a strongly acidic medium (pH 1.2). Salicylamide, in CS, results in a smaller percentage of drug release than that of CA. Dosage forms that prolong release can maintain drug concentrations for longer periods in a more optimal therapeutic range while minimizing toxicity.

Acknowledgement

The authors thank the Ministry of Research, Technology and Higher Education, Indonesia for the research support fund through the Riset Pengembangan Ilmu Pengetahuan dan Teknologi (IPTEK) FY 2016 scheme. We also thank Kapsulindo Nusantara, Inc. for supporting the production of nutraceutical hardshell carrageenan-based capsules.

  1. Conflicts of interest: The authors declare that there is no conflict of interest.

References

[1] Stegemann S. Hard gelatin capsules today and tomorrow. Capsugel Library; 2017. 3 p.Search in Google Scholar

[2] Al-Tabakha M.M. HPMC capsules: current status and future prospects. J. Pharm Pharmaceut Sci. 2010;13(3):428-42.10.18433/J3K881Search in Google Scholar

[3] FAO-UN, Sosial and economic dimension of carrageenan seaweed farming; 2013.Search in Google Scholar

[4] Stanley N. Production, properties and uses of carrageenan: FMC Corporation. Marine Colloids Division 5 Maple Street, Rockland Maine 04841. Corporate Document Repository: FAO. USA; 2011.Search in Google Scholar

[5] Necas J, Bartosikova L. Valuable biomolecules from nine North Atlantic red microalgae: amino acids, fatty acids, carotenoids, minerals and metals. Vet. Med. - Czech. 2013;58(4):187-205.10.17221/6758-VETMEDSearch in Google Scholar

[6] Li L, Ni R, Shao Y, Mao S. Carrageenan and its applications in drug delivery. Carbohydr. Polym. 2014;103:1-11.10.1016/j.carbpol.2013.12.008Search in Google Scholar

[7] Campo VL, Kawano DF, Silva Jr. DB, Carvalho I. Carrageenans: Biological properties, chemical modifications and structural analysis – A review. Carbohydr. Polym. 2009;77:167-80.10.1016/j.carbpol.2009.01.020Search in Google Scholar

[8] Venugopal V. Marine polysaccharide: Food applications. Taylor and Francis Group, New York; 2011. 207-211 p.Search in Google Scholar

[9] Guan J, Li L, Mao S. In: Venkatesan J, Anil S, Kim S-K. Application of Carrageenan in Advance Drug Delivery, in Seaweed Polysaccharide: Isolation, Biological, and Biomedical Applications, Cambridge: Elsevier Inc; 2017: 286-288 p.10.1016/B978-0-12-809816-5.00015-3Search in Google Scholar

[10] Fertah M. In: Venkatesan J, Anil S, Kim S-K. Application of Carrageenan in Advance Drug Delivery, in Seaweed Polysaccharide: Isolation, Biological, and Biomedical Applications, Cambridge: Elsevier Inc; 2017: 11 p.Search in Google Scholar

[11] www.nutraceuticalsworld.com [Internet]. Missy L: Hard Capsule Technologies Address Consumer Concerns. c2019 [Cited 2019 May 2019]. Available from www.nutraceuticalsworld.comSearch in Google Scholar

[12] Singhvi G, Singh M. Review: In vitro drug release characterization models. Int. J. Pharm. 2011;2(1):77-84.Search in Google Scholar

[13] Costa P, Lobo JMS, Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 2001;13:123-33.10.1016/S0928-0987(01)00095-1Search in Google Scholar

[14] Liu J, Zhan X, Wan J, Wang Y, Wang C. Review for carrageenan-based pharmaceutical biomaterials: Favourable physical features versus adverse biological effects. Carbohydr. Polym. 2015;121:27-36.10.1016/j.carbpol.2014.11.063Search in Google Scholar PubMed

[15] Wong SR, Durazo AR, Rivera PZ, Maldonado A, Barbosa MEM, Velaz I, Tanori J. Drug release properties of diflusinal from layer-by-layer self-assembled k-carrageenan/chitosan nanocapsules: effect of deposited layers. Polymers. 2018;0:760.10.3390/polym10070760Search in Google Scholar PubMed PubMed Central

[16] Onyishi IV, Chime SA, Egwu E. Application of k-Carrageenan as a sustained release matrix in floating tablets containing sodium salicylate. Afr. J. Pharm. Pharmacol. 2013;7:2667-73.Search in Google Scholar

[17] Bettini R, Bonferoni MC, Colombo P, Zanelotti L, Caramella C. Drug release kinetics and front movement in matrix tablets containing diltiazem or meteloprolol/ƛ-carrageenan complexes. BioMed Research International. 2014;671532.10.1155/2014/671532Search in Google Scholar PubMed PubMed Central

[18] Dash S, Murthy PN, Nath L, Chowdhur P. Kinetics modeling on drug release from controlled drug delivery systems. Acta. Pol. Pharm., 2010;67(3):217-23.Search in Google Scholar

[19] Glube N, Moos LV, Duchateau G. Capsule shell material impacts the in vitro disintegration and dissolution behaviour of a green tea extract. Results Pharma. Sci. 2013;3:1-6.10.1016/j.rinphs.2013.08.002Search in Google Scholar PubMed PubMed Central

[20] Todica M, Nagy EM, Niculaescu C, Stan O, Cioica N, Pop CV. XRD investigation of some thermal degraded starch based materials, Investigation of some thermal degraded starch. J. Spectrosc. 2016:1-6.10.1155/2016/9605312Search in Google Scholar

[21] Fu S, Thacker A, Sperger DM, Boni RL, Buckner IS, Velankar S, Munson EJ, Block LH. Relevance of rheological properties of sodium alginate in solution to calcium alginate gel properties. AAPS PharmSciTech. 2011;12(2):1-8.10.1208/s12249-011-9587-0Search in Google Scholar

[22] Fu Y, Kao WJ. Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems. Expert Opin Drug Deliv. 2010;7(4):429-44.10.1517/17425241003602259Search in Google Scholar

[23] Chiwele I, Jones BE, Podczeck F. The shell dissolution of various empty hard capsules. Chem. Pharm. Bull. 2000;48(7):951-6.10.1248/cpb.48.951Search in Google Scholar

[24] Liu J, Zhan X, Wan Y. Wang, Wang C. Review for carrageenan-based pharmaceutical biomaterials: Favourable physical features versus adverse biological effects. Carbohydr. Polym. 2015; 121: 27-36.10.1016/j.carbpol.2014.11.063Search in Google Scholar

[25] Peppas NA, Sahlin JJ. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int. J. Pharm. 1989;57:169-72.10.1016/0378-5173(89)90306-2Search in Google Scholar

[26] Higuchi T. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 1963;52:1145-9.10.1002/jps.2600521210Search in Google Scholar PubMed

[27] Zhang R, Fan Q, Yang M, Cheng K, Lu X, Zhang L, Huang W, Cheng Z. Engineering melanin nanoparticles as an efficient drug-delivery system for imaging-guided chemotheraphy. Adv. Mater. 2015;27:5063-9.10.1002/adma.201502201Search in Google Scholar PubMed

Received: 2018-11-27
Accepted: 2019-10-19
Published Online: 2020-04-07

© 2020 Pratiwi Pudjiastuti et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Regular Articles
  2. Electrochemical antioxidant screening and evaluation based on guanine and chitosan immobilized MoS2 nanosheet modified glassy carbon electrode (guanine/CS/MoS2/GCE)
  3. Kinetic models of the extraction of vanillic acid from pumpkin seeds
  4. On the maximum ABC index of bipartite graphs without pendent vertices
  5. Estimation of the total antioxidant potential in the meat samples using thin-layer chromatography
  6. Molecular dynamics simulation of sI methane hydrate under compression and tension
  7. Spatial distribution and potential ecological risk assessment of some trace elements in sediments and grey mangrove (Avicennia marina) along the Arabian Gulf coast, Saudi Arabia
  8. Amino-functionalized graphene oxide for Cr(VI), Cu(II), Pb(II) and Cd(II) removal from industrial wastewater
  9. Chemical composition and in vitro activity of Origanum vulgare L., Satureja hortensis L., Thymus serpyllum L. and Thymus vulgaris L. essential oils towards oral isolates of Candida albicans and Candida glabrata
  10. Effect of excess Fluoride consumption on Urine-Serum Fluorides, Dental state and Thyroid Hormones among children in “Talab Sarai” Punjab Pakistan
  11. Design, Synthesis and Characterization of Novel Isoxazole Tagged Indole Hybrid Compounds
  12. Comparison of kinetic and enzymatic properties of intracellular phosphoserine aminotransferases from alkaliphilic and neutralophilic bacteria
  13. Green Organic Solvent-Free Oxidation of Alkylarenes with tert-Butyl Hydroperoxide Catalyzed by Water-Soluble Copper Complex
  14. Ducrosia ismaelis Asch. essential oil: chemical composition profile and anticancer, antimicrobial and antioxidant potential assessment
  15. DFT calculations as an efficient tool for prediction of Raman and infra-red spectra and activities of newly synthesized cathinones
  16. Influence of Chemical Osmosis on Solute Transport and Fluid Velocity in Clay Soils
  17. A New fatty acid and some triterpenoids from propolis of Nkambe (North-West Region, Cameroon) and evaluation of the antiradical scavenging activity of their extracts
  18. Antiplasmodial Activity of Stigmastane Steroids from Dryobalanops oblongifolia Stem Bark
  19. Rapid identification of direct-acting pancreatic protectants from Cyclocarya paliurus leaves tea by the method of serum pharmacochemistry combined with target cell extraction
  20. Immobilization of Pseudomonas aeruginosa static biomass on eggshell powder for on-line preconcentration and determination of Cr (VI)
  21. Assessment of methyl 2-({[(4,6-dimethoxypyrimidin-2-yl)carbamoyl] sulfamoyl}methyl)benzoate through biotic and abiotic degradation modes
  22. Stability of natural polyphenol fisetin in eye drops Stability of fisetin in eye drops
  23. Production of a bioflocculant by using activated sludge and its application in Pb(II) removal from aqueous solution
  24. Molecular Properties of Carbon Crystal Cubic Structures
  25. Synthesis and characterization of calcium carbonate whisker from yellow phosphorus slag
  26. Study on the interaction between catechin and cholesterol by the density functional theory
  27. Analysis of some pharmaceuticals in the presence of their synthetic impurities by applying hybrid micelle liquid chromatography
  28. Two mixed-ligand coordination polymers based on 2,5-thiophenedicarboxylic acid and flexible N-donor ligands: the protective effect on periodontitis via reducing the release of IL-1β and TNF-α
  29. Incorporation of silver stearate nanoparticles in methacrylate polymeric monoliths for hemeprotein isolation
  30. Development of ultrasound-assisted dispersive solid-phase microextraction based on mesoporous carbon coated with silica@iron oxide nanocomposite for preconcentration of Te and Tl in natural water systems
  31. N,N′-Bis[2-hydroxynaphthylidene]/[2-methoxybenzylidene]amino]oxamides and their divalent manganese complexes: Isolation, spectral characterization, morphology, antibacterial and cytotoxicity against leukemia cells
  32. Determination of the content of selected trace elements in Polish commercial fruit juices and health risk assessment
  33. Diorganotin(iv) benzyldithiocarbamate complexes: synthesis, characterization, and thermal and cytotoxicity study
  34. Keratin 17 is induced in prurigo nodularis lesions
  35. Anticancer, antioxidant, and acute toxicity studies of a Saudi polyherbal formulation, PHF5
  36. LaCoO3 perovskite-type catalysts in syngas conversion
  37. Comparative studies of two vegetal extracts from Stokesia laevis and Geranium pratense: polyphenol profile, cytotoxic effect and antiproliferative activity
  38. Fragmentation pattern of certain isatin–indole antiproliferative conjugates with application to identify their in vitro metabolic profiles in rat liver microsomes by liquid chromatography tandem mass spectrometry
  39. Investigation of polyphenol profile, antioxidant activity and hepatoprotective potential of Aconogonon alpinum (All.) Schur roots
  40. Lead discovery of a guanidinyl tryptophan derivative on amyloid cascade inhibition
  41. Physicochemical evaluation of the fruit pulp of Opuntia spp growing in the Mediterranean area under hard climate conditions
  42. Electronic structural properties of amino/hydroxyl functionalized imidazolium-based bromide ionic liquids
  43. New Schiff bases of 2-(quinolin-8-yloxy)acetohydrazide and their Cu(ii), and Zn(ii) metal complexes: their in vitro antimicrobial potentials and in silico physicochemical and pharmacokinetics properties
  44. Treatment of adhesions after Achilles tendon injury using focused ultrasound with targeted bFGF plasmid-loaded cationic microbubbles
  45. Synthesis of orotic acid derivatives and their effects on stem cell proliferation
  46. Chirality of β2-agonists. An overview of pharmacological activity, stereoselective analysis, and synthesis
  47. Fe3O4@urea/HITh-SO3H as an efficient and reusable catalyst for the solvent-free synthesis of 7-aryl-8H-benzo[h]indeno[1,2-b]quinoline-8-one and indeno[2′,1′:5,6]pyrido[2,3-d]pyrimidine derivatives
  48. Adsorption kinetic characteristics of molybdenum in yellow-brown soil in response to pH and phosphate
  49. Enhancement of thermal properties of bio-based microcapsules intended for textile applications
  50. Exploring the effect of khat (Catha edulis) chewing on the pharmacokinetics of the antiplatelet drug clopidogrel in rats using the newly developed LC-MS/MS technique
  51. A green strategy for obtaining anthraquinones from Rheum tanguticum by subcritical water
  52. Cadmium (Cd) chloride affects the nutrient uptake and Cd-resistant bacterium reduces the adsorption of Cd in muskmelon plants
  53. Removal of H2S by vermicompost biofilter and analysis on bacterial community
  54. Structural cytotoxicity relationship of 2-phenoxy(thiomethyl)pyridotriazolopyrimidines: Quantum chemical calculations and statistical analysis
  55. A self-breaking supramolecular plugging system as lost circulation material in oilfield
  56. Synthesis, characterization, and pharmacological evaluation of thiourea derivatives
  57. Application of drug–metal ion interaction principle in conductometric determination of imatinib, sorafenib, gefitinib and bosutinib
  58. Synthesis and characterization of a novel chitosan-grafted-polyorthoethylaniline biocomposite and utilization for dye removal from water
  59. Optimisation of urine sample preparation for shotgun proteomics
  60. DFT investigations on arylsulphonyl pyrazole derivatives as potential ligands of selected kinases
  61. Treatment of Parkinson’s disease using focused ultrasound with GDNF retrovirus-loaded microbubbles to open the blood–brain barrier
  62. New derivatives of a natural nordentatin
  63. Fluorescence biomarkers of malignant melanoma detectable in urine
  64. Study of the remediation effects of passivation materials on Pb-contaminated soil
  65. Saliva proteomic analysis reveals possible biomarkers of renal cell carcinoma
  66. Withania frutescens: Chemical characterization, analgesic, anti-inflammatory, and healing activities
  67. Design, synthesis and pharmacological profile of (−)-verbenone hydrazones
  68. Synthesis of magnesium carbonate hydrate from natural talc
  69. Stability-indicating HPLC-DAD assay for simultaneous quantification of hydrocortisone 21 acetate, dexamethasone, and fluocinolone acetonide in cosmetics
  70. A novel lactose biosensor based on electrochemically synthesized 3,4-ethylenedioxythiophene/thiophene (EDOT/Th) copolymer
  71. Citrullus colocynthis (L.) Schrad: Chemical characterization, scavenging and cytotoxic activities
  72. Development and validation of a high performance liquid chromatography/diode array detection method for estrogen determination: Application to residual analysis in meat products
  73. PCSK9 concentrations in different stages of subclinical atherosclerosis and their relationship with inflammation
  74. Development of trace analysis for alkyl methanesulfonates in the delgocitinib drug substance using GC-FID and liquid–liquid extraction with ionic liquid
  75. Electrochemical evaluation of the antioxidant capacity of natural compounds on glassy carbon electrode modified with guanine-, polythionine-, and nitrogen-doped graphene
  76. A Dy(iii)–organic framework as a fluorescent probe for highly selective detection of picric acid and treatment activity on human lung cancer cells
  77. A Zn(ii)–organic cage with semirigid ligand for solvent-free cyanosilylation and inhibitory effect on ovarian cancer cell migration and invasion ability via regulating mi-RNA16 expression
  78. Polyphenol content and antioxidant activities of Prunus padus L. and Prunus serotina L. leaves: Electrochemical and spectrophotometric approach and their antimicrobial properties
  79. The combined use of GC, PDSC and FT-IR techniques to characterize fat extracted from commercial complete dry pet food for adult cats
  80. MALDI-TOF MS profiling in the discovery and identification of salivary proteomic patterns of temporomandibular joint disorders
  81. Concentrations of dioxins, furans and dioxin-like PCBs in natural animal feed additives
  82. Structure and some physicochemical and functional properties of water treated under ammonia with low-temperature low-pressure glow plasma of low frequency
  83. Mesoscale nanoparticles encapsulated with emodin for targeting antifibrosis in animal models
  84. Amine-functionalized magnetic activated carbon as an adsorbent for preconcentration and determination of acidic drugs in environmental water samples using HPLC-DAD
  85. Antioxidant activity as a response to cadmium pollution in three durum wheat genotypes differing in salt-tolerance
  86. A promising naphthoquinone [8-hydroxy-2-(2-thienylcarbonyl)naphtho[2,3-b]thiophene-4,9-dione] exerts anti-colorectal cancer activity through ferroptosis and inhibition of MAPK signaling pathway based on RNA sequencing
  87. Synthesis and efficacy of herbicidal ionic liquids with chlorsulfuron as the anion
  88. Effect of isovalent substitution on the crystal structure and properties of two-slab indates BaLa2−xSmxIn2O7
  89. Synthesis, spectral and thermo-kinetics explorations of Schiff-base derived metal complexes
  90. An improved reduction method for phase stability testing in the single-phase region
  91. Comparative analysis of chemical composition of some commercially important fishes with an emphasis on various Malaysian diets
  92. Development of a solventless stir bar sorptive extraction/thermal desorption large volume injection capillary gas chromatographic-mass spectrometric method for ultra-trace determination of pyrethroids pesticides in river and tap water samples
  93. A turbidity sensor development based on NL-PI observers: Experimental application to the control of a Sinaloa’s River Spirulina maxima cultivation
  94. Deep desulfurization of sintering flue gas in iron and steel works based on low-temperature oxidation
  95. Investigations of metallic elements and phenolics in Chinese medicinal plants
  96. Influence of site-classification approach on geochemical background values
  97. Effects of ageing on the surface characteristics and Cu(ii) adsorption behaviour of rice husk biochar in soil
  98. Adsorption and sugarcane-bagasse-derived activated carbon-based mitigation of 1-[2-(2-chloroethoxy)phenyl]sulfonyl-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl) urea-contaminated soils
  99. Antimicrobial and antifungal activities of bifunctional cooper(ii) complexes with non-steroidal anti-inflammatory drugs, flufenamic, mefenamic and tolfenamic acids and 1,10-phenanthroline
  100. Application of selenium and silicon to alleviate short-term drought stress in French marigold (Tagetes patula L.) as a model plant species
  101. Screening and analysis of xanthine oxidase inhibitors in jute leaves and their protective effects against hydrogen peroxide-induced oxidative stress in cells
  102. Synthesis and physicochemical studies of a series of mixed-ligand transition metal complexes and their molecular docking investigations against Coronavirus main protease
  103. A study of in vitro metabolism and cytotoxicity of mephedrone and methoxetamine in human and pig liver models using GC/MS and LC/MS analyses
  104. A new phenyl alkyl ester and a new combretin triterpene derivative from Combretum fragrans F. Hoffm (Combretaceae) and antiproliferative activity
  105. Erratum
  106. Erratum to: A one-step incubation ELISA kit for rapid determination of dibutyl phthalate in water, beverage and liquor
  107. Review Articles
  108. Sinoporphyrin sodium, a novel sensitizer for photodynamic and sonodynamic therapy
  109. Natural products isolated from Casimiroa
  110. Plant description, phytochemical constituents and bioactivities of Syzygium genus: A review
  111. Evaluation of elastomeric heat shielding materials as insulators for solid propellant rocket motors: A short review
  112. Special Issue on Applied Biochemistry and Biotechnology 2019
  113. An overview of Monascus fermentation processes for monacolin K production
  114. Study on online soft sensor method of total sugar content in chlorotetracycline fermentation tank
  115. Studies on the Anti-Gouty Arthritis and Anti-hyperuricemia Properties of Astilbin in Animal Models
  116. Effects of organic fertilizer on water use, photosynthetic characteristics, and fruit quality of pear jujube in northern Shaanxi
  117. Characteristics of the root exudate release system of typical plants in plateau lakeside wetland under phosphorus stress conditions
  118. Characterization of soil water by the means of hydrogen and oxygen isotope ratio at dry-wet season under different soil layers in the dry-hot valley of Jinsha River
  119. Composition and diurnal variation of floral scent emission in Rosa rugosa Thunb. and Tulipa gesneriana L.
  120. Preparation of a novel ginkgolide B niosomal composite drug
  121. The degradation, biodegradability and toxicity evaluation of sulfamethazine antibiotics by gamma radiation
  122. Special issue on Monitoring, Risk Assessment and Sustainable Management for the Exposure to Environmental Toxins
  123. Insight into the cadmium and zinc binding potential of humic acids derived from composts by EEM spectra combined with PARAFAC analysis
  124. Source apportionment of soil contamination based on multivariate receptor and robust geostatistics in a typical rural–urban area, Wuhan city, middle China
  125. Special Issue on 13th JCC 2018
  126. The Role of H2C2O4 and Na2CO3 as Precipitating Agents on The Physichochemical Properties and Photocatalytic Activity of Bismuth Oxide
  127. Preparation of magnetite-silica–cetyltrimethylammonium for phenol removal based on adsolubilization
  128. Topical Issue on Agriculture
  129. Size-dependent growth kinetics of struvite crystals in wastewater with calcium ions
  130. The effect of silica-calcite sedimentary rock contained in the chicken broiler diet on the overall quality of chicken muscles
  131. Physicochemical properties of selected herbicidal products containing nicosulfuron as an active ingredient
  132. Lycopene in tomatoes and tomato products
  133. Fluorescence in the assessment of the share of a key component in the mixing of feed
  134. Sulfur application alleviates chromium stress in maize and wheat
  135. Effectiveness of removal of sulphur compounds from the air after 3 years of biofiltration with a mixture of compost soil, peat, coconut fibre and oak bark
  136. Special Issue on the 4th Green Chemistry 2018
  137. Study and fire test of banana fibre reinforced composites with flame retardance properties
  138. Special Issue on the International conference CosCI 2018
  139. Disintegration, In vitro Dissolution, and Drug Release Kinetics Profiles of k-Carrageenan-based Nutraceutical Hard-shell Capsules Containing Salicylamide
  140. Synthesis of amorphous aluminosilicate from impure Indonesian kaolin
  141. Special Issue on the International Conf on Science, Applied Science, Teaching and Education 2019
  142. Functionalization of Congo red dye as a light harvester on solar cell
  143. The effect of nitrite food preservatives added to se’i meat on the expression of wild-type p53 protein
  144. Biocompatibility and osteoconductivity of scaffold porous composite collagen–hydroxyapatite based coral for bone regeneration
  145. Special Issue on the Joint Science Congress of Materials and Polymers (ISCMP 2019)
  146. Effect of natural boron mineral use on the essential oil ratio and components of Musk Sage (Salvia sclarea L.)
  147. A theoretical and experimental study of the adsorptive removal of hexavalent chromium ions using graphene oxide as an adsorbent
  148. A study on the bacterial adhesion of Streptococcus mutans in various dental ceramics: In vitro study
  149. Corrosion study of copper in aqueous sulfuric acid solution in the presence of (2E,5E)-2,5-dibenzylidenecyclopentanone and (2E,5E)-bis[(4-dimethylamino)benzylidene]cyclopentanone: Experimental and theoretical study
  150. Special Issue on Chemistry Today for Tomorrow 2019
  151. Diabetes mellitus type 2: Exploratory data analysis based on clinical reading
  152. Multivariate analysis for the classification of copper–lead and copper–zinc glasses
  153. Special Issue on Advances in Chemistry and Polymers
  154. The spatial and temporal distribution of cationic and anionic radicals in early embryo implantation
  155. Special Issue on 3rd IC3PE 2020
  156. Magnetic iron oxide/clay nanocomposites for adsorption and catalytic oxidation in water treatment applications
  157. Special Issue on IC3PE 2018/2019 Conference
  158. Exergy analysis of conventional and hydrothermal liquefaction–esterification processes of microalgae for biodiesel production
  159. Advancing biodiesel production from microalgae Spirulina sp. by a simultaneous extraction–transesterification process using palm oil as a co-solvent of methanol
  160. Topical Issue on Applications of Mathematics in Chemistry
  161. Omega and the related counting polynomials of some chemical structures
  162. M-polynomial and topological indices of zigzag edge coronoid fused by starphene
Downloaded on 16.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/chem-2020-0028/html
Scroll to top button